Currently, the only effective treatment for pulmonary emphysema is alpha-1 antiproteinase supplementation in a relatively small subset of COPD patients with a genetic deficiency of this protein [48,49,50,51]. The gene discussed is SERPINA1; the disease is chronic obstructive pulmonary disease.